Accro Bioscience completes USD50m Series C financing

Atisama Therapeutics reports progress in Phase 1 study of RB042

Mabwell's clinical trial application for 9MW5211 cleared by US FDA

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

GSK secures US and EU fast-track designations for efimosfermin in MASH

FDA expands Sanofi and Regeneron's Dupixent approval to younger children with chronic spontaneous urticaria

AstraZeneca reports third positive Phase III trial for tozorakimab in COPD

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

Trellus Health renews licensing agreement with Pfizer

EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria

GSK secures China approval for Exdensur to treat nasal polyp condition

Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration